| __timestamp | Cytokinetics, Incorporated | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 406114000 |
| Thursday, January 1, 2015 | 19667000 | 449119000 |
| Friday, January 1, 2016 | 27823000 | 502892000 |
| Sunday, January 1, 2017 | 36468000 | 544156000 |
| Monday, January 1, 2018 | 31282000 | 683530000 |
| Tuesday, January 1, 2019 | 39610000 | 736942000 |
| Wednesday, January 1, 2020 | 52820000 | 854233000 |
| Friday, January 1, 2021 | 96803000 | 1451683000 |
| Saturday, January 1, 2022 | 177977000 | 1416967000 |
| Sunday, January 1, 2023 | 173612000 | 1343105000 |
Infusing magic into the data realm
In the competitive landscape of biopharmaceuticals, understanding the financial strategies of industry leaders is crucial. Jazz Pharmaceuticals plc and Cytokinetics, Incorporated have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Jazz Pharmaceuticals consistently outpaced Cytokinetics, with SG&A expenses peaking at approximately $1.45 billion in 2021, a staggering 250% increase from 2014. In contrast, Cytokinetics saw a more modest rise, with expenses growing by over 900% to reach around $178 million in 2022. This divergence highlights Jazz's aggressive market expansion and operational scale, while Cytokinetics' growth reflects strategic investments in research and development. As the biopharma sector evolves, these financial insights offer a window into the strategic priorities and market positioning of these two influential companies.
AbbVie Inc. and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
Selling, General, and Administrative Costs: Catalent, Inc. vs Cytokinetics, Incorporated
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Cytokinetics, Incorporated
Cost Management Insights: SG&A Expenses for Jazz Pharmaceuticals plc and Soleno Therapeutics, Inc.
Jazz Pharmaceuticals plc and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Axsome Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and Geron Corporation
Cytokinetics, Incorporated or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?